Balchem Other Current Liab vs Non Current Liabilities Total Analysis
BCPC Stock | USD 182.44 2.13 1.18% |
Balchem financial indicator trend analysis is way more than just evaluating Balchem prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Balchem is a good investment. Please check the relationship between Balchem Other Current Liab and its Non Current Liabilities Total accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Balchem. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey. For information on how to trade Balchem Stock refer to our How to Trade Balchem Stock guide.
Other Current Liab vs Non Current Liabilities Total
Other Current Liab vs Non Current Liabilities Total Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Balchem Other Current Liab account and Non Current Liabilities Total. At this time, the significance of the direction appears to have strong relationship.
The correlation between Balchem's Other Current Liab and Non Current Liabilities Total is 0.7. Overlapping area represents the amount of variation of Other Current Liab that can explain the historical movement of Non Current Liabilities Total in the same time period over historical financial statements of Balchem, assuming nothing else is changed. The correlation between historical values of Balchem's Other Current Liab and Non Current Liabilities Total is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Other Current Liab of Balchem are associated (or correlated) with its Non Current Liabilities Total. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Non Current Liabilities Total has no effect on the direction of Other Current Liab i.e., Balchem's Other Current Liab and Non Current Liabilities Total go up and down completely randomly.
Correlation Coefficient | 0.7 |
Relationship Direction | Positive |
Relationship Strength | Significant |
Other Current Liab
Non Current Liabilities Total
Most indicators from Balchem's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Balchem current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Balchem. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey. For information on how to trade Balchem Stock refer to our How to Trade Balchem Stock guide.At present, Balchem's Enterprise Value Over EBITDA is projected to increase based on the last few years of reporting. The current year's Enterprise Value Multiple is expected to grow to 24.58, whereas Tax Provision is forecasted to decline to about 24.2 M.
2021 | 2022 | 2023 | 2024 (projected) | Gross Profit | 243.2M | 280.5M | 302.1M | 317.2M | Total Revenue | 799.0M | 942.4M | 922.4M | 968.6M |
Balchem fundamental ratios Correlations
Click cells to compare fundamentals
Balchem Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Balchem fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 1.2B | 1.2B | 1.2B | 1.6B | 1.6B | 1.7B | |
Short Long Term Debt Total | 258.9M | 176.4M | 124.6M | 440.6M | 330.3M | 346.9M | |
Other Current Liab | 52.5M | 68.3M | 85.2M | 72.4M | 79.6M | 83.6M | |
Total Current Liabilities | 92.3M | 94.4M | 143.8M | 140.0M | 148.5M | 155.9M | |
Total Stockholder Equity | 743.7M | 828.2M | 877.0M | 938.3M | 1.1B | 1.1B | |
Property Plant And Equipment Net | 224.2M | 236.5M | 246.8M | 290.8M | 295.9M | 310.7M | |
Net Debt | 182.9M | 79.0M | 5.3M | 374.0M | 265.9M | 279.2M | |
Retained Earnings | 590.9M | 656.7M | 732.1M | 814.5M | 897.5M | 942.4M | |
Non Current Assets Total | 900.7M | 899.0M | 877.1M | 1.3B | 1.3B | 1.3B | |
Net Receivables | 93.4M | 98.2M | 117.4M | 131.6M | 125.3M | 131.5M | |
Common Stock Shares Outstanding | 32.5M | 32.5M | 32.7M | 32.4M | 32.4M | 30.0M | |
Liabilities And Stockholders Equity | 1.2B | 1.2B | 1.2B | 1.6B | 1.6B | 1.7B | |
Non Current Liabilities Total | 319.8M | 243.2M | 178.5M | 546.2M | 394.7M | 414.5M | |
Inventory | 83.9M | 70.6M | 91.1M | 119.7M | 109.5M | 115.0M | |
Other Current Assets | 11.9M | 13.5M | 10.5M | 18.0M | 15.0M | 15.7M | |
Other Stockholder Equity | 156.1M | 165.2M | 147.7M | 128.8M | 145.7M | 152.9M | |
Total Liab | 412.0M | 337.6M | 322.3M | 686.2M | 543.2M | 570.4M | |
Property Plant And Equipment Gross | 224.2M | 236.5M | 246.8M | 290.8M | 508.7M | 534.1M | |
Total Current Assets | 254.9M | 266.9M | 322.2M | 335.8M | 314.2M | 330.0M | |
Accumulated Other Comprehensive Income | (5.6M) | 4.2M | (5.0M) | (7.2M) | 8.7M | 9.1M | |
Cash | 65.7M | 84.6M | 103.2M | 66.6M | 64.4M | 46.2M | |
Cash And Short Term Investments | 65.7M | 84.6M | 103.2M | 66.6M | 64.4M | 46.2M | |
Non Currrent Assets Other | 8.6M | 11.3M | 11.7M | (52.0M) | 12.9M | 13.5M | |
Accounts Payable | 37.3M | 23.7M | 56.2M | 57.3M | 55.5M | 58.3M | |
Intangible Assets | 143.9M | 121.7M | 94.7M | 213.3M | 191.2M | 200.8M | |
Common Stock Total Equity | 2.2M | 2.2M | 2.2M | 2.1M | 2.5M | 1.6M | |
Common Stock | 2.2M | 2.2M | 2.2M | 2.1M | 2.2M | 1.6M | |
Other Liab | 64.6M | 68.0M | 69.9M | 89.6M | 103.0M | 108.2M | |
Property Plant Equipment | 216.9M | 228.1M | 246.8M | 271.4M | 312.1M | 327.7M | |
Long Term Debt | 256.4M | 174.1M | 108.6M | 440.6M | 309.6M | 325.0M | |
Good Will | 524.0M | 529.5M | 523.9M | 769.5M | 778.9M | 817.9M | |
Other Assets | 4.1M | 19.7M | 11.7M | 10.8M | 12.4M | 13.1M | |
Net Tangible Assets | 75.7M | 298.8M | 258.4M | 168.8M | 194.1M | 129.0M | |
Retained Earnings Total Equity | 590.9M | 656.7M | 732.1M | 814.5M | 936.7M | 469.1M | |
Long Term Debt Total | 163.4M | 256.4M | 174.1M | 122.3M | 140.6M | 173.3M | |
Capital Surpluse | 174.2M | 173.0M | 147.7M | 128.8M | 148.1M | 135.9M | |
Deferred Long Term Liab | 58.5M | 51.4M | 46.5M | 62.8M | 72.2M | 43.5M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Balchem offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Balchem's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Balchem Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Balchem Stock:Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Balchem. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey. For information on how to trade Balchem Stock refer to our How to Trade Balchem Stock guide.You can also try the Portfolio Center module to all portfolio management and optimization tools to improve performance of your portfolios.
Is Specialty Chemicals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Balchem. If investors know Balchem will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Balchem listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.144 | Dividend Share 0.79 | Earnings Share 3.72 | Revenue Per Share 29.208 | Quarterly Revenue Growth 0.043 |
The market value of Balchem is measured differently than its book value, which is the value of Balchem that is recorded on the company's balance sheet. Investors also form their own opinion of Balchem's value that differs from its market value or its book value, called intrinsic value, which is Balchem's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Balchem's market value can be influenced by many factors that don't directly affect Balchem's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Balchem's value and its price as these two are different measures arrived at by different means. Investors typically determine if Balchem is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Balchem's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.